Trial
NCT03554707
SGT-53 in Children With Recurrent or Progressive CNS Malignancies
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
SynerGene Therapeutics, Inc.
Collaborators
—
Condition
Childhood CNS Tumor
Intervention
SGT-53
Why stopped
The grant intended to support this trial as ultimately not funded. This trial was not initiated,. No patients were enrolled.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-08